Patient Education in the Clinical Management of Pessary
A Randomized Controlled Trial of the Effectiveness of Patient Education in the Clinical Management of Pessary
1 other identifier
interventional
280
1 country
1
Brief Summary
This study is a prospective, randomized, controlled, single-blinded, multi-center clinical trial. Symptomatic patients with pelvic organ prolapse (POP) stage II, III or IV arranged to undergo pessary treatment will be randomized into either the experimental group or the control group. All patients will receive conventional verbal/paper instruction and counseling from a specialized doctor or nurse before pessary fitting, and the experimental group will receive additional patient education in the form of a re-watchable video. The video mainly includes a short introduction of pessary treatment for pelvic organ prolapse, tips and tricks for wearing and self-management of pessary, possible adverse reactions and remedy. All patients will receive regular pessary fitting and be followed up for 1 year. Self-assessment questionnaires will be used to assess the patients' willingness to pessary treatment, anxiety status, treatment satisfaction and efficacy, and to assess the patients' self-management, complications and treatment adherence. Then the differences between the two groups will be compared.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jun 2024
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 10, 2024
CompletedFirst Posted
Study publicly available on registry
May 29, 2024
CompletedStudy Start
First participant enrolled
June 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
November 1, 2026
May 29, 2024
May 1, 2024
2.4 years
May 10, 2024
May 22, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Continued usage with satisfaction
Continued usage of the pessary and have very much or much improvement in the patient impression of improvement (PGI-I) questionnaire at 1 year.
12 months after pessary fitting.
Secondary Outcomes (8)
Knowledge of pessary
Baseline and at pessary fitting.
Willingness to treatment
Baseline, at pessary fitting, and 3 and 12 months after successful pessary fitting.
Anxiety about pessary use
Baseline and at pessary fitting.
Ability to self-manage
3 and 12 months after successful pessary fitting.
Treatment-related symptoms and complications
3 and 12 months after successful pessary fitting.
- +3 more secondary outcomes
Study Arms (2)
the conventional education plus video education group
EXPERIMENTALWatch video as well as receive conventional guidance.
the conventional education group
ACTIVE COMPARATORReceive conventional guidance.
Interventions
A re-watchable video provided before pessary fitting which mainly includes a short introduction of pessary treatment for pelvic organ prolapse, tips and tricks for wearing and self-management of pessary, possible adverse reactions and remedy.
Conventional verbal/paper instruction and counseling from a specialized doctor or nurse before pessary fitting.
Eligibility Criteria
You may qualify if:
- Symptomatic pelvic organ prolapse of stage II\~IV
- Ability to participate in clinical trial and follow-up
- The patient and family understand the study, are willing to participate in the 1-year study, and provide written informed consent
You may not qualify if:
- Acute phase of infection of the internal and/or external genital tracts
- Genital fistula
- Suspected or untreated lower genital tract tumors
- Abnormally elevated intra-abdominal pressure (e.g., ascites, tumors)
- Life expectancy less than 1 year
- Cognitive or language communication disorders
- Unable to watch video (e.g., blindness)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Peking Union Medical College Hospitallead
- Peking University People's Hospitalcollaborator
- Shandong Universitycollaborator
- Tongji Hospitalcollaborator
- Third Military Medical Universitycollaborator
- Changsha Hospital for Maternal and Child Health Carecollaborator
- Hangzhou Women's Hospitalcollaborator
- Shenzhen People's Hospitalcollaborator
- Foshan Women's and Children's Hospitalcollaborator
Study Sites (1)
Peking Union Medical College Hospital
Beijing, Beijing Municipality, 100730, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Lan Zhu, MD
Peking Union Medical College Hospital
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 10, 2024
First Posted
May 29, 2024
Study Start
June 1, 2024
Primary Completion (Estimated)
November 1, 2026
Study Completion (Estimated)
November 1, 2026
Last Updated
May 29, 2024
Record last verified: 2024-05
Data Sharing
- IPD Sharing
- Will not share